Developer docs
API playgroundTry for free, no card

Search company profiles

HistoWiz

Full company profile

uuid00039eo

Namestring
HistoWiz
Legal namestring
HistoWiz, Inc.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

HistoWiz is a contract research organization (CRO) that provides automated histopathology and digital pathology services to biomedical researchers, founded around 2012-2013 and headquartered in Long Island City, New York. The company combines a physical histology laboratory with a cloud-based digital pathology platform called PathologyMap, digitizing every stained slide via whole slide imaging and hosting the largest preclinical data collection cited in the company's positioning — over 2 million whole slide images produced and 700,000+ active images serving 7,000+ users across 550+ organizations. Service offerings include precision histology (H&E, special stains) with 3-day turnaround, immunostaining with 400+ validated antibodies, multiplex immunofluorescence (Akoya PSP, CST SignalStar, Cell IDx, Ultivue InSituPlex), slide archiving, block management with 24-hour retrieval, on-demand telepathology consultation through 135+ board-certified pathologists across 88+ specialties, and quantitative image analysis.

The core technology stack is PathologyMap 2.0, a cloud-based platform that added AI-powered automated tissue segmentation and quality control (98%+ accuracy) in June 2024, integrating third-party AI tools from AIRA Matrix and supporting universal slide format ingestion (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF). In 2024 the company also introduced GLP-compliant histology workflows, a Digital Block Management solution, and spatial multiomics/ISH services. Revenue is generated primarily through quote-based project pricing for professional services, supplemented by subscription/recurring access to the PathologyMap platform and a pay-per-use AI apps library; pricing is not publicly disclosed. Go-to-market is hybrid: a self-serve online platform (app.histowiz.com) with integrated FedEx shipping, a field sales team for enterprise pharma accounts, and a regional Champion Program dropbox network across the New York Metro Area that has processed 50,000+ samples. HistoWiz is a privately held, venture-backed company, having raised a $32.25 million Series A in October 2021 led by Vivo Capital with Asahi Kasei and venBio Partners. The company serves both pharmaceutical/biotech clients (GSK, Boehringer Ingelheim, Takeda, Johnson & Johnson) and academic medical centers (Stanford, MSKCC, Fred Hutchinson, Dana-Farber, University of Pennsylvania), with CEO Linh Hoang leading as of end of 2024.

Short descriptiontext

HistoWiz provides automated histopathology and digital pathology services to biomedical researchers, combining a cloud-based whole slide imaging platform (PathologyMap 2.0) with GLP-compliant histology, immunostaining, multiplex IF, and on-demand pathology consultation for pharma, biotech, and academic clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBrooklyn, United States
HQ citystring
Brooklyn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
histopathology services, digital pathology platform, tissue slide imaging, immunohistochemistry staining, quantitative image analysis
Industry5 codes
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHLAAAMAI
Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Histopathology Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model8 records
1Histology Services
TypeProfessional Services
Description

Precision histology services including tissue processing, slide generation, H&E staining, special stains. Turnaround time as fast as 3 days. GLP and non-GLP services available.

home.histowiz.com
2Immunostaining Services
TypeProfessional Services
Description

Advanced IHC and IF staining for protein visualization with 400+ validated antibodies. Includes multiplex immunofluorescence (mIF) services.

home.histowiz.com
3Digital Pathology Platform (PathologyMap)
TypeSubscription Recurring
Description

Cloud-based platform for slide viewing, data management, collaboration and analysis. Hosts the largest collection of preclinical data for AI-driven and QC tools.

home.histowiz.com
4Slide Archiving and Storage
TypeManaged Services
Description

Digitization and storage of glass slide collections with high-throughput scanning for virtually every tissue type. Block storage services with 24-hour retrieval.

home.histowiz.com
5Path Consult (Telepathology)
TypeProfessional Services
Description

Online, on-demand consultation with 100+ board-certified pathologists. Network includes toxicology pathologists for GLP pathology consultations.

home.histowiz.com
6Quantitative Image Analysis
TypeProfessional Services
Description

Expert-led image analysis services providing objective assessments using HALO, Visopharm, QuPath, and proprietary AI tools.

home.histowiz.com
7AI Apps (Pay-per-use)
TypeUsage Based
Description

AI-powered analysis tools accessible through PathologyMap platform with pay-per-use pricing model - no extra software setup or subscription fees.

home.histowiz.com
8Multiomics/ISH
TypeProfessional Services
Description

Spatial multiomics services combining RNA-ISH with protein detection, experienced on 100+ customized developmental projects.

Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Custom project-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

No standard pricing tiers publicly listed. Customers reach out to sales team or generate PO. Blanket POs with standard MSA/SOW available. Credit cards accepted through secure online order form.

home.histowiz.com
2AI Apps pay-per-use
ModelUsage-basedBilling cadencePay-as-you-go
Notes

AI apps library offers rapid one-click analysis with pay-per-use model - no extra software setup or subscription fees required.

home.histowiz.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1PathologyMap™
Description

Cloud-based digital pathology platform for whole slide imaging, AI-powered analysis, data management, collaboration, and quality control for histopathology research.

home.histowiz.com
+3 more records
Core offering1 text field

HistoWiz provides automated histopathology services for biomedical researchers, converting tissue specimens into high-quality digital slides in as few as 3 days. The company delivers precision histology, IHC/IF immunostaining with 400+ validated antibodies, slide archiving, telepathology consultation with board-certified pathologists, quantitative image analysis, and multiomics/ISH services. Its cloud-based PathologyMap platform hosts the largest collection of preclinical whole slide images and offers AI-powered tissue segmentation and quality control.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 3-day turnaround time from tissue specimens to high-quality digital slides
+4 more records
Product and service8 records
1Precision Histology
CategoryHistology Services
Description

High-quality tissue processing, embedding, sectioning, and slide generation for biomedical researchers, available in both GLP and non-GLP compliant workflows with turnaround times as fast as 3 days.

2Immunostaining
CategoryImmunostaining Services
Description

Advanced immunohistochemistry (IHC) and immunofluorescence (IF) staining using 400+ validated antibodies, including multiplex immunofluorescence (mIF) for up to 9 channels, serving protein visualization needs in research samples.

3Slide Archiving
CategorySlide Digitization Services
Description

Digitization of glass slide collections via high-throughput whole slide imaging (WSI) scanning for virtually every tissue type, with images stored on the cloud-based PathologyMap platform.

4Path Consult (Telepathology)
CategoryTelepathology Consultation
Description

Online, on-demand consultation service connecting researchers with 100+ board-certified pathologists across over 88 specialties, including toxicology pathologists for GLP pathology consultations.

5Quantitative Image Analysis
CategoryImage Analysis Services
Description

Expert-led image analysis using HALO, Visopharm, QuPath, and proprietary AI tools for cell segmentation, biomarker quantification, tumor detection, and region of interest classification.

6Multiomics / ISH
CategoryMultiomics Services
Description

Spatial multiomics services combining HCR RNA-ISH with multiplex IF for simultaneous detection of transcribed RNA and translated protein on one slide, including Akoya PSP (up to 6 markers), CST SignalStar, Cell IDx, and Ultivue InSituPlex (up to 12 markers).

7PathologyMap Platform
CategoryDigital Pathology Software Platform
Description

Cloud-based digital pathology platform for slide viewing, data management, collaboration, and AI-powered analysis. Hosts 700,000+ active whole slide images, supports universal image format upload (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF), and includes an AI Apps library with pay-per-use pricing.

8Block Manager
CategorySample Management Services
Description

Digital block management solution providing 24/7 access to FFPE research samples with real-time tracking, 24-hour retrieval time, and integrated histology services for streamlined workflows.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or Integration
Description

AI tool integration partnership where AIRA Matrix's digital pathology AI tools are integrated into HistoWiz's PathologyMap platform, making them available to pharma, biotech and academic institutions globally. PathologyMap achieves over 98% accuracy in automated quality control for pathology slides using these integrated AI tools.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

First organization to partner with Akoya in developing the PSP (Phenocode Signature Panels) platform for multiplex immunofluorescence. Offers up to 6 markers within a single tissue section with 10-day turnaround time. Provides researchers with rapid, detailed insights into complex tissue samples.

Strategic tierCoreTypeTechnology or Integration
Description

Proud member of Akoya's qualified CRO service provider network, demonstrating expertise in multiplex immunofluorescence workflows and adherence to Akoya's quality standards.

Strategic tierCoreTypeTechnology or Integration
Description

Uses Leica Bond RX automated stainer for all staining procedures, following Standard Operating Procedures and fully automated workflow for consistent, high-quality results.

Strategic tierCoreTypeTechnology or Integration
Description

Uses HALO image analysis software as primary tool for automated quantitative image analysis, providing objective assessments of staining intensity and tissue characteristics.

Strategic tierCoreTypeTechnology or Integration
Description

Uses Visiopharm image analysis software alongside HALO for quantitative image analysis services, providing additional options for biomarker quantification and tissue classification.

7QuPath
Strategic tierCoreTypeTechnology or Integration
Description

Uses QuPath (open-source) for image analysis in addition to commercial solutions, providing flexibility for different analysis requirements.

home.histowiz.com
Strategic tierCoreTypeTechnology or Integration
Description

Priority probe development partner for in situ hybridization (ISH) services. Provides access to ACD's RNA detection technologies for spatial transcriptomics applications.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for HCR (Hybridization Chain Reaction) RNA-ISH platform, enabling simultaneous detection of transcribed RNA and translated protein on one slide. On-demand webinar collaboration for customer education.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI-powered digital pathology platform serving pharma, biotech, and academic clients with both services and software. Most direct competitor in the AI-enabled preclinical/clinical pathology space, with overlapping customer base and similar focus on data-driven tissue analysis.

TypeDirect peer
Description

Tissue image analysis CRO specializing in quantitative pathology, IHC/IF, and digital slide services for pharma/biotech preclinical and clinical programs. Direct peer in the regulated histology + image analysis service offering.

TypeDirect peer
Description

Provider of multiplex spatial biology services (MIBI technology) and digital pathology for translational and clinical research. Overlaps with HistoWiz in multiplex IF, IHC services, and pathology image analysis for oncology/immunology research.

TypeDirect peer
Description

Developer of HALO image analysis software used widely for digital pathology quantification. Both partner and competitor — HistoWiz uses HALO for IA services while Indica also sells directly to pharma and academic customers in the same workflow.

TypeEmerging player
Description

Multiplex immunofluorescence platform company (OPAL/PhenoCode) with whom HistoWiz has a Flagship co-development partnership. Comparable in multiplex IF services for translational research but operates more as an instrument/reagent vendor with growing CRO offerings.

TypeEmerging player
Description

Spatial biology services provider offering multiplex IF, spatial transcriptomics, and digital pathology services to pharma and academic clients. Comparable service catalog for translational and preclinical research customers.

TypeBroad incumbent
Description

Global CRO offering preclinical histology, toxicology pathology, and GLP-compliant services. Far larger scale and broader service menu; competes with HistoWiz for pharma preclinical histology spend but does not focus on the academic/PLG segment.

TypeBroad incumbent
Description

Large preclinical CRO with integrated histology, toxicology, and bioanalysis services for global pharma/biotech. Competes for enterprise pharma histology contracts at large scale.

TypeBroad incumbent
Description

Provider of histology instruments, Aperio whole slide imaging scanners, and digital pathology software. Overlaps in WSI infrastructure and downstream pathology workflow; HistoWiz depends on Leica Bond RX stainer while Leica/Aperio competes on enterprise digital pathology platforms.

TypeDirect peer
Description

Quantitative image analysis software provider for digital pathology with significant pharma/biotech adoption. Competes with HistoWiz in biomarker quantification, tissue classification, and AI-driven image analysis services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HistoWiz

Histopathology Serviceshome.histowiz.com

HistoWiz provides automated histopathology and digital pathology services to biomedical researchers, combining a cloud-based whole slide imaging platform (PathologyMap 2.0) with GLP-compliant histology, immunostaining, multiplex IF, and on-demand pathology consultation for pharma, biotech, and academic clients.

What HistoWiz does

HistoWiz is a contract research organization (CRO) that provides automated histopathology and digital pathology services to biomedical researchers, founded around 2012-2013 and headquartered in Long Island City, New York. The company combines a physical histology laboratory with a cloud-based digital pathology platform called PathologyMap, digitizing every stained slide via whole slide imaging and hosting the largest preclinical data collection cited in the company's positioning — over 2 million whole slide images produced and 700,000+ active images serving 7,000+ users across 550+ organizations. Service offerings include precision histology (H&E, special stains) with 3-day turnaround, immunostaining with 400+ validated antibodies, multiplex immunofluorescence (Akoya PSP, CST SignalStar, Cell IDx, Ultivue InSituPlex), slide archiving, block management with 24-hour retrieval, on-demand telepathology consultation through 135+ board-certified pathologists across 88+ specialties, and quantitative image analysis.

The core technology stack is PathologyMap 2.0, a cloud-based platform that added AI-powered automated tissue segmentation and quality control (98%+ accuracy) in June 2024, integrating third-party AI tools from AIRA Matrix and supporting universal slide format ingestion (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF). In 2024 the company also introduced GLP-compliant histology workflows, a Digital Block Management solution, and spatial multiomics/ISH services. Revenue is generated primarily through quote-based project pricing for professional services, supplemented by subscription/recurring access to the PathologyMap platform and a pay-per-use AI apps library; pricing is not publicly disclosed. Go-to-market is hybrid: a self-serve online platform (app.histowiz.com) with integrated FedEx shipping, a field sales team for enterprise pharma accounts, and a regional Champion Program dropbox network across the New York Metro Area that has processed 50,000+ samples. HistoWiz is a privately held, venture-backed company, having raised a $32.25 million Series A in October 2021 led by Vivo Capital with Asahi Kasei and venBio Partners. The company serves both pharmaceutical/biotech clients (GSK, Boehringer Ingelheim, Takeda, Johnson & Johnson) and academic medical centers (Stanford, MSKCC, Fred Hutchinson, Dana-Farber, University of Pennsylvania), with CEO Linh Hoang leading as of end of 2024.

HistoWiz firmographics

Firmographics
Name
HistoWiz
Legal name
HistoWiz, Inc.
Website
https://home.histowiz.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
HistoWiz provides automated histopathology and digital pathology services to biomedical researchers, combining a cloud-based whole slide imaging platform (PathologyMap 2.0) with GLP-compliant histology, immunostaining, multiplex IF, and on-demand pathology consultation for pharma, biotech, and academic clients.
Ownership category
akta.pro rank

HistoWiz industry classification

Industry
Product category
Histopathology Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
SECONDARYHLAAAMAI
Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Histopathology services
  • Digital pathology platform
  • Tissue slide imaging
  • Immunohistochemistry staining
  • Quantitative image analysis

Where HistoWiz is headquartered

Location

Headquarters

HQ city
Brooklyn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HistoWiz business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Histology Services: Precision histology services including tissue processing, slide generation, H&E staining, special stains. Turnaround time as fast as 3 days. GLP and non-GLP services available.
  2. Immunostaining Services: Advanced IHC and IF staining for protein visualization with 400+ validated antibodies. Includes multiplex immunofluorescence (mIF) services.
  3. Digital Pathology Platform (PathologyMap): Cloud-based platform for slide viewing, data management, collaboration and analysis. Hosts the largest collection of preclinical data for AI-driven and QC tools.
  4. Slide Archiving and Storage: Digitization and storage of glass slide collections with high-throughput scanning for virtually every tissue type. Block storage services with 24-hour retrieval.
  5. Path Consult (Telepathology): Online, on-demand consultation with 100+ board-certified pathologists. Network includes toxicology pathologists for GLP pathology consultations.
  6. Quantitative Image Analysis: Expert-led image analysis services providing objective assessments using HALO, Visopharm, QuPath, and proprietary AI tools.
  7. AI Apps (Pay-per-use): AI-powered analysis tools accessible through PathologyMap platform with pay-per-use pricing model - no extra software setup or subscription fees.
  8. Multiomics/ISH: Spatial multiomics services combining RNA-ISH with protein detection, experienced on 100+ customized developmental projects.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCustom project-based pricing
Usage-basedPay-as-you-goAI Apps pay-per-use

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

HistoWiz product offering

Product offering

Core offering

HistoWiz provides automated histopathology services for biomedical researchers, converting tissue specimens into high-quality digital slides in as few as 3 days. The company delivers precision histology, IHC/IF immunostaining with 400+ validated antibodies, slide archiving, telepathology consultation with board-certified pathologists, quantitative image analysis, and multiomics/ISH services. Its cloud-based PathologyMap platform hosts the largest collection of preclinical whole slide images and offers AI-powered tissue segmentation and quality control.

Differentiator

Problem solved

Functional benefit

Brands

  • PathologyMap™: Cloud-based digital pathology platform for whole slide imaging, AI-powered analysis, data management, collaboration, and quality control for histopathology research.
  • PathologyMap 2.0
  • Path Consult
  • Block Manager

Products and services

  • Precision Histology High-quality tissue processing, embedding, sectioning, and slide generation for biomedical researchers, available in both GLP and non-GLP compliant workflows with turnaround times as fast as 3 days.
  • Immunostaining Advanced immunohistochemistry (IHC) and immunofluorescence (IF) staining using 400+ validated antibodies, including multiplex immunofluorescence (mIF) for up to 9 channels, serving protein visualization needs in research samples.
  • Slide Archiving Digitization of glass slide collections via high-throughput whole slide imaging (WSI) scanning for virtually every tissue type, with images stored on the cloud-based PathologyMap platform.
  • Path Consult (Telepathology) Online, on-demand consultation service connecting researchers with 100+ board-certified pathologists across over 88 specialties, including toxicology pathologists for GLP pathology consultations.
  • Quantitative Image Analysis Expert-led image analysis using HALO, Visopharm, QuPath, and proprietary AI tools for cell segmentation, biomarker quantification, tumor detection, and region of interest classification.
  • Multiomics / ISH Spatial multiomics services combining HCR RNA-ISH with multiplex IF for simultaneous detection of transcribed RNA and translated protein on one slide, including Akoya PSP (up to 6 markers), CST SignalStar, Cell IDx, and Ultivue InSituPlex (up to 12 markers).
  • PathologyMap Platform Cloud-based digital pathology platform for slide viewing, data management, collaboration, and AI-powered analysis. Hosts 700,000+ active whole slide images, supports universal image format upload (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF), and includes an AI Apps library with pay-per-use pricing.
  • Block Manager Digital block management solution providing 24/7 access to FFPE research samples with real-time tracking, 24-hour retrieval time, and integrated histology services for streamlined workflows.

Quantifiable outcome

  • 3-day turnaround time from tissue specimens to high-quality digital slides
  • +4 more outcomes

Companies that use HistoWiz

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

HistoWiz technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature12 records

HistoWiz partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and flagship.

  • AIRA MatrixcoreTechnology or IntegrationAI tool integration partnership where AIRA Matrix's digital pathology AI tools are integrated into HistoWiz's PathologyMap platform, making them available to pharma, biotech and academic institutions globally. PathologyMap achieves over 98% accuracy in automated quality control for pathology slides using these integrated AI tools.
  • Akoya BiosciencesflagshipStrategic or Co-development PartnerFirst organization to partner with Akoya in developing the PSP (Phenocode Signature Panels) platform for multiplex immunofluorescence. Offers up to 6 markers within a single tissue section with 10-day turnaround time. Provides researchers with rapid, detailed insights into complex tissue samples.
  • Akoya Biosciences (Qualified CRO Service Provider)coreTechnology or IntegrationProud member of Akoya's qualified CRO service provider network, demonstrating expertise in multiplex immunofluorescence workflows and adherence to Akoya's quality standards.
  • Leica MicrosystemscoreTechnology or IntegrationUses Leica Bond RX automated stainer for all staining procedures, following Standard Operating Procedures and fully automated workflow for consistent, high-quality results.
  • Indica Labs (HALO)coreTechnology or IntegrationUses HALO image analysis software as primary tool for automated quantitative image analysis, providing objective assessments of staining intensity and tissue characteristics.
  • VisiopharmcoreTechnology or IntegrationUses Visiopharm image analysis software alongside HALO for quantitative image analysis services, providing additional options for biomarker quantification and tissue classification.
  • QuPathcoreTechnology or IntegrationUses QuPath (open-source) for image analysis in addition to commercial solutions, providing flexibility for different analysis requirements.
  • ACD (Advanced Cell Diagnostics)coreTechnology or IntegrationPriority probe development partner for in situ hybridization (ISH) services. Provides access to ACD's RNA detection technologies for spatial transcriptomics applications.
  • Molecular Instruments (HCR)coreTechnology or IntegrationPartnership for HCR (Hybridization Chain Reaction) RNA-ISH platform, enabling simultaneous detection of transcribed RNA and translated protein on one slide. On-demand webinar collaboration for customer education.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

HistoWiz competitors and assessment

Company assessment

Direct peers

  • PathAI: AI-powered digital pathology platform serving pharma, biotech, and academic clients with both services and software. Most direct competitor in the AI-enabled preclinical/clinical pathology space, with overlapping customer base and similar focus on data-driven tissue analysis.
  • Flagship Biosciences: Tissue image analysis CRO specializing in quantitative pathology, IHC/IF, and digital slide services for pharma/biotech preclinical and clinical programs. Direct peer in the regulated histology + image analysis service offering.
  • IONpath: Provider of multiplex spatial biology services (MIBI technology) and digital pathology for translational and clinical research. Overlaps with HistoWiz in multiplex IF, IHC services, and pathology image analysis for oncology/immunology research.
  • Indica Labs: Developer of HALO image analysis software used widely for digital pathology quantification. Both partner and competitor — HistoWiz uses HALO for IA services while Indica also sells directly to pharma and academic customers in the same workflow.
  • Visiopharm: Quantitative image analysis software provider for digital pathology with significant pharma/biotech adoption. Competes with HistoWiz in biomarker quantification, tissue classification, and AI-driven image analysis services.

Emerging players

  • Akoya Biosciences: Multiplex immunofluorescence platform company (OPAL/PhenoCode) with whom HistoWiz has a Flagship co-development partnership. Comparable in multiplex IF services for translational research but operates more as an instrument/reagent vendor with growing CRO offerings.
  • Canopy Biosciences (Bruker): Spatial biology services provider offering multiplex IF, spatial transcriptomics, and digital pathology services to pharma and academic clients. Comparable service catalog for translational and preclinical research customers.

Broad incumbents

  • Charles River Laboratories: Global CRO offering preclinical histology, toxicology pathology, and GLP-compliant services. Far larger scale and broader service menu; competes with HistoWiz for pharma preclinical histology spend but does not focus on the academic/PLG segment.
  • WuXi AppTec: Large preclinical CRO with integrated histology, toxicology, and bioanalysis services for global pharma/biotech. Competes for enterprise pharma histology contracts at large scale.
  • Leica Biosystems (Danaher): Provider of histology instruments, Aperio whole slide imaging scanners, and digital pathology software. Overlaps in WSI infrastructure and downstream pathology workflow; HistoWiz depends on Leica Bond RX stainer while Leica/Aperio competes on enterprise digital pathology platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

HistoWiz social profiles

Digital presence

HistoWiz financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HistoWiz leadership team

Management profile

Number of profiles

Profiles5 records

HistoWiz funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HistoWiz M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HistoWiz

What does HistoWiz do?

HistoWiz provides automated histopathology services for biomedical researchers, converting tissue specimens into high-quality digital slides in as few as 3 days. The company delivers precision histology, IHC/IF immunostaining with 400+ validated antibodies, slide archiving, telepathology consultation with board-certified pathologists, quantitative image analysis, and multiomics/ISH services. Its cloud-based PathologyMap platform hosts the largest collection of preclinical whole slide images and offers AI-powered tissue segmentation and quality control.

Is HistoWiz a public or private company?

HistoWiz is a private company. It is classified as venture growth investor backed and is currently operating.

When was HistoWiz founded?

HistoWiz was founded in 2013. It employs 11 to 50 people.

Where is HistoWiz based?

HistoWiz is headquartered in Brooklyn, United States, in the North America region.

How does HistoWiz make money?

Eight revenue lines are on record. Histology Services are the primary driver. The others are immunostaining Services, digital Pathology Platform (PathologyMap), slide Archiving and Storage, path Consult (Telepathology), quantitative Image Analysis, AI Apps (Pay-per-use) and multiomics/ISH.

Who are HistoWiz's main competitors?

Direct peers on record are PathAI, Flagship Biosciences, IONpath, Indica Labs and Visiopharm. Emerging players are Akoya Biosciences and Canopy Biosciences (Bruker). Broad incumbents are Charles River Laboratories, WuXi AppTec and Leica Biosystems (Danaher).

Does HistoWiz have an API?

No public API is recorded for HistoWiz.

What industry is HistoWiz in?

HistoWiz's product category is Histopathology Services. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services, with a secondary code of HLAGAEAC, Anatomic Pathology & Histopathology (Trial Support). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaAccelerating cancer diagnosis with AI-based pathologyThe article profiles Akash Parvatikar, who leads R&D of large-scale digital pathology platforms at Histowiz, a New York-based company, and has played a key role in building PathologyMap, an AI-enabled platform that achieves over 98% accuracy in automated quality control for pathology slides. PathologyMap integrates AI tools developed by AIRA Matrix, an India-based digital pathology AI company, making them available to pharma, biotech and academic institutions globally. The article discusses how digital pathology could help address India's shortage of trained pathologists in rural and semi-urban areas, while noting challenges including the high cost of slide scanners (Rs 50 lakh to Rs 2 crore) and the need for national data standards and regulatory frameworks.openPR.comFuture Perspective: Key Trends Shaping the Segmentation Artificial Intelligence (AI) For Pathology Slides Market Until 2030The segmentation AI market for pathology slides is projected to grow to $2.98 billion by 2030, driven by deep learning integration, automated segmentation tools, and demand for real-time slide analysis, with a compound annual growth rate of 23.9%. A notable development was Tempus AI Inc.'s acquisition of Paige.AI Inc. in August 2026 for approximately $81.2 million, aimed at enhancing Tempus AI's capabilities in digital pathology through Paige's algorithms for tissue and cell segmentation. Additionally, US-based HistoWiz Inc. launched PathologyMap 2.0 in June 2024, an AI-powered platform offering automated tissue segmentation and quality control for whole slide image analysis.HistowizWhy Pathology Labs Should Adopt AI and Digital Solutions NowA promotional post argues that pathology labs should adopt AI and digital pathology tools to handle rising case volumes, improve diagnostic accuracy, enable remote collaboration, and streamline block and slide management. It highlights HistoWiz's offerings, including PathologyMap 2.0, an AI apps library covering cell segmentation, tumor detection and biomarker quantification, and a Block Management Solution.TmcnetGRM Information Management and HistoWiz Build Upon Partner Relationship with Histowiz Becoming a GRM ClientHistoWiz became a client of GRM Information Management for pathology storage, with its slide collection stored in a temperature-controlled vault at GRM's Jersey City facility. The partnership expands GRM's pathology services, including digital workflow automation via VisualVault, and both companies cite mutual quality appreciation.YahooGRM Information Management and HistoWiz Build Upon Partner Relationship with Histowiz Becoming a GRM ClientGRM Information Management and HistoWiz announced a partnership, with HistoWiz becoming a client of GRM's pathology storage services. GRM will store HistoWiz's slide collection in a temperature-controlled vault at its Jersey City facility, while servicing existing New York metro clients. The partnership aims to offer a comprehensive suite of pathology services.Business Wire BlogGRM Information Management and HistoWiz Build Upon Partner Relationship with Histowiz Becoming a GRM ClientHistoWiz became a client of GRM's pathology storage services, moving its slide collection to GRM's Jersey City facility. The partnership allows both organizations to offer a comprehensive suite of pathology services, including analysis, digitization, and long-term storage.YahooHistoWiz Launches AI-powered PathologyMap™ 2.0 for Histopathology Slide ImagesHistoWiz launched PathologyMap 2.0, an AI-powered digital slide management platform for histopathology. It adds one-click AI analysis for quality control and tissue segmentation, plus flexible metadata integration and lightning-fast search. The platform is available now for all HistoWiz customers.Business Wire BlogHistoWiz Launches AI-powered PathologyMap™ 2.0 for Histopathology Slide ImagesHistoWiz launched PathologyMap 2.0, an AI-powered digital slide management platform for histopathology. It adds one-click AI analysis, flexible metadata integration, and third-party app support, available now to all customers.Business Wire BlogHistoWiz Launches AI-powered PathologyMap™ 2.0 for Histopathology Slide ImagesHistoWiz launched PathologyMap 2.0, an AI-powered digital slide management platform for histopathology. It adds one-click AI analysis, automated quality control, and third-party app integration, available now to customers.Business Wire BlogHistoWiz Expands Histology and Pathology Service Offerings to Include GLPHistoWiz added GLP-compliant lab services including routine histology and immunohistochemistry, plus pathology consultation for GLP studies. The expansion targets drug, vaccine, cosmetics, and food/chemical safety companies, leveraging its pre-clinical pathology expertise. The company's laboratory adheres to GLP standards for regulatory submissions.